Vol 47 No 9

Urologist elected to AMA Board of Trustees

August 26, 2019

Willie Underwood, III, MD, MSc, MPH, the Buffalo, NY urologist elected to the American Medical Association’s Board of Trustees in June, believes physicians must step up and help influence governmental decisions designed to improve and expand health care for all Americans.

How to improve patients’ access to their health information

August 30, 2019

"Patient access to health information-whether it resides in a medical record, a lab company’s system, or an insurance company records-is a right firmly protected by federal laws and regulations," writes Robert A. Dowling, MD.

What’s your biggest frustration with prior authorization?

September 03, 2019

"One is the delay in delivering care. If I order surgery that requires prior authorization, it won’t always come through in a timely manner, and that impacts patients’ quality of life," says one urologist.

Sipuleucel-T significantly improves OS in African-Americans vs. Caucasians

September 05, 2019

Analyses of data collected in PROCEED, a large real-world registry, corroborate phase III study findings demonstrating that sipuleucel-T (Provenge) treatment for metastatic castrate-resistant prostate cancer has a particular benefit for improving overall survival in African-American men.

Apalutamide efficacious in previously treated patients

September 10, 2019

Researchers say the use of apalutamide (Erleada) in patients with high-risk, nonmetastatic castration-resistant prostate cancer improves metastasis-free survival in patients who have previously undergone radical prostatectomy or external radiotherapy-regardless of the type of treatment they received.

PSMA PET/CT beneficial for prostate cancer staging

September 10, 2019

A new study suggests that prostate-specific membrane antigen positron emission tomography/computed tomography may be a highly beneficial tool for initial staging of high-risk and high-intermediate-risk prostate cancer.

Salvage LND may help delay recurrence

September 11, 2019

A preliminary study of the use of salvage lymph node dissection in patients with nonmetastatic, castration-resistant prostate cancer indicates the potential to delay disease recurrence as well as the use of systemic therapies through this approach.

AUA, SUFU offer guidance on incontinence after prostate treatment

September 12, 2019

Earlier in 2019, the AUA and the Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction published a joint guideline on the subject of incontinence after prostate treatment. In this interview, Jaspreet S. Sandhu, MD, a member of this guideline’s panel, explains the rationale behind the guideline and summarizes its key points.